» Articles » PMID: 4992997

Immunological Basis of the Adenovirus 8-9 Cross-reaction

Overview
Journal J Virol
Date 1970 Dec 1
PMID 4992997
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The dedecon and hexon components of adenovirus types 8 and 9 have been extensively purified for use in establishing the basis of the cross-reaction between these types. Dodecons, the complete hemagglutinins, were purified 304- to 362-fold by fluorocarbon extraction, calcium phosphate batch chromatography, and ion-exchange column chromatography. Hexons, the group complement-fixation (CF) antigens, were purified 230- to 240-fold by erythrocyte adsorption, ion-exchange chromatography, and exclusion chromatography. Component antisera prepared in rabbits were tested in reciprocal fashion with crude virus and dodecon and hexon components. By hemagglutination-inhibition (HI), the dodecons of types 8 and 9 demonstrated the same predominantly one-sided relationship characteristic of the crude antigens. Some neutralizing activity was associated with both dodecons and hexons of each type. However, combining anti-dodecon and anti-hexon sera or producing antisera against the combined dodecon-hexon components resulted in neutralizing titers which were identical to titers obtained with antisera against the crude virus harvests. Dedecons of each type appear to share at least one antigenic determinant with hexons of the same type, and this determinant may reside on the vertex capsomere. Hexons possess group- and type-specific determinants, as shown by CF, neutralization, and immunodiffusion tests, and may exhibit some minor relationship between types 8 and 9. The results with the purified components are consistent with the predominantly one-sided antigenic relationship between types 8 and 9 in the conventional HI tests and the largely type-specific relationship by neutralization tests.

Citing Articles

Serological and genetic characterisation of a unique strain of adenovirus involved in an outbreak of epidemic keratoconjunctivitis.

Adhikary A, Inada T, Banik U, Mukouyama A, Ikeda Y, Noda M J Clin Pathol. 2004; 57(4):411-6.

PMID: 15047747 PMC: 1770264. DOI: 10.1136/jcp.2003.012500.


Molecular characterization of the type-specific gamma-determinant located on the adenovirus fiber.

Eiz B, Pring-Akerblom P J Virol. 1997; 71(9):6576-81.

PMID: 9261379 PMC: 191935. DOI: 10.1128/JVI.71.9.6576-6581.1997.


Application of a solid-phase immunofluorometric assay to the selection of monoclonal antibody specific for the adenovirus group-reactive hexon antigen.

Hierholzer J, Phillips D, HUMPHREY D, Coombs R, Reimer C Arch Virol. 1984; 80(1):1-10.

PMID: 6367709 DOI: 10.1007/BF01315289.


Antigenically intermediate human adenovirus strain associated with conjunctivitis.

Hierholzer J, Rodriguez Jr F J Clin Microbiol. 1981; 13(2):395-7.

PMID: 6259204 PMC: 273797. DOI: 10.1128/jcm.13.2.395-397.1981.


The immune response to virus infections.

Onions D Vet Immunol Immunopathol. 1983; 4(1-2):237-77.

PMID: 6191431 PMC: 7119848. DOI: 10.1016/0165-2427(83)90059-4.


References
1.
Norrby E, Skaaret P . The relationship between soluble antigens and the virion of adenovirus type 3. 3. Immunological identification of fiber antigen and isolated vertex capsomer antigen. Virology. 1967; 32(3):489-502. DOI: 10.1016/0042-6822(67)90301-7. View

2.
Stevens D, Schaeffer M, Fox J, BRANDT C, Romano M . Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes. Am J Epidemiol. 1967; 86(3):617-33. DOI: 10.1093/oxfordjournals.aje.a120771. View

3.
Gelderblom H, Bauer H, Frank H, Wigand R . The structure of group II adenoviruses. J Gen Virol. 1967; 1(4):553-60. DOI: 10.1099/0022-1317-1-4-553. View

4.
Pettersson U, Philipson L, Hoglund S . Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology. 1967; 33(4):575-90. DOI: 10.1016/0042-6822(67)90057-8. View

5.
Kjellen L, Pereira H . Role of adenovirus antigens in the induction of virus neutralizing antibody. J Gen Virol. 1968; 2(1):177-85. DOI: 10.1099/0022-1317-2-1-177. View